PMID- 30103955 OWN - NLM STAT- MEDLINE DCOM- 20190627 LR - 20190627 IS - 1878-5883 (Electronic) IS - 0022-510X (Linking) VI - 391 DP - 2018 Aug 15 TI - Epilepsy treatment patterns among patients with tuberous sclerosis complex. PG - 104-108 LID - S0022-510X(18)30261-2 [pii] LID - 10.1016/j.jns.2018.06.011 [doi] AB - INTRODUCTION: Tuberous sclerosis complex (TSC) is a rare congenital disorder often associated with epilepsy. However, real-world treatment patterns for epilepsy in patients with TSC are not yet well categorized. METHODS: This study included patients with TSC and epilepsy from fifteen clinics in the United States and one in Belgium who were enrolled in the TSC Natural History Database (2006-2014). Patient demographics and epilepsy treatment patterns, including the use of anti-epileptic drugs (AEDs), epilepsy surgeries, and dietary therapies were assessed. RESULTS: Of the 1328 patients with TSC in the database, 1110 (83.6%) were diagnosed with epilepsy. The median age of epilepsy diagnosis was 0.7 years. Of those who received treatment for epilepsy (92.3%), 99.5% were prescribed AEDs, 25.3% underwent surgery, 7.9% were prescribed special diets, and 1% were prescribed mammalian target of rapamycin (mTOR) inhibitors. Of the patients receiving AEDs, over half (64.5%) used >/=3 different AEDs, and 22.5% underwent surgical treatment following AED initiation. Of the patients who underwent surgery, 35.1% had subsequent surgery. CONCLUSION: The use of multiple AEDs and surgical interventions may indicate a need for new therapies to reduce the treatment burden among patients with TSC and epilepsy. CI - Copyright (c) 2018. Published by Elsevier B.V. FAU - Song, Jinlin AU - Song J AD - Analysis Group, Inc., 111 Huntington Ave, Floor 14, Boston, MA 02199, United States. FAU - Swallow, Elyse AU - Swallow E AD - Analysis Group, Inc., 111 Huntington Ave, Floor 14, Boston, MA 02199, United States. Electronic address: elyse.swallow@analysisgroup.com. FAU - Said, Qayyim AU - Said Q AD - Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ 07936, United States. FAU - Peeples, Miranda AU - Peeples M AD - Analysis Group, Inc., 111 Huntington Ave, Floor 14, Boston, MA 02199, United States. FAU - Meiselbach, Mark AU - Meiselbach M AD - Analysis Group, Inc., 111 Huntington Ave, Floor 14, Boston, MA 02199, United States. FAU - Signorovitch, James AU - Signorovitch J AD - Analysis Group, Inc., 111 Huntington Ave, Floor 14, Boston, MA 02199, United States. FAU - Kohrman, Michael AU - Kohrman M AD - Akron Children's Hospital, 1 Perkins Square, Akron, OH 44308, United States. FAU - Korf, Bruce AU - Korf B AD - University of Alabama at Birmingham, 1720 2(nd) Ave S, Birmingham, AL 35294, United States. FAU - Krueger, Darcy AU - Krueger D AD - Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, United States. FAU - Wong, Michael AU - Wong M AD - Washington University in Saint Louis, 1 Brookings Dr, St. Louis, MO 63130, United States. FAU - Sparagana, Steven AU - Sparagana S AD - Texas Scottish Rite Hospital for Children, 2222 Wellborn St, Dallas, TX 75219, United States. LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20180615 PL - Netherlands TA - J Neurol Sci JT - Journal of the neurological sciences JID - 0375403 RN - 0 (Anticonvulsants) SB - IM MH - Adolescent MH - Anticonvulsants/therapeutic use MH - Child MH - Child, Preschool MH - Diet Therapy/trends MH - Epilepsy/*complications/epidemiology/genetics/*therapy MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Neurosurgical Procedures/trends MH - Retrospective Studies MH - Treatment Outcome MH - Tuberous Sclerosis/*complications/epidemiology/genetics/*therapy MH - Young Adult OTO - NOTNLM OT - Anti-epileptic drugs OT - Epilepsy OT - Treatment patterns OT - Tuberous Sclerosis Natural History Database OT - Tuberous sclerosis complex EDAT- 2018/08/15 06:00 MHDA- 2019/06/30 06:00 CRDT- 2018/08/15 06:00 PHST- 2018/03/15 00:00 [received] PHST- 2018/06/01 00:00 [revised] PHST- 2018/06/13 00:00 [accepted] PHST- 2018/08/15 06:00 [entrez] PHST- 2018/08/15 06:00 [pubmed] PHST- 2019/06/30 06:00 [medline] AID - S0022-510X(18)30261-2 [pii] AID - 10.1016/j.jns.2018.06.011 [doi] PST - ppublish SO - J Neurol Sci. 2018 Aug 15;391:104-108. doi: 10.1016/j.jns.2018.06.011. Epub 2018 Jun 15.